Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) Net Income towards Common Stockholders: 2019-2024

Historic Net Income towards Common Stockholders for P3 Health Partners (PIII) over the last 6 years, with FY2024 value amounting to -$310.4 million.

  • P3 Health Partners' Net Income towards Common Stockholders rose 3246.38% to -$69.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$286.5 million, marking a year-over-year decrease of 1445.37%. This contributed to the annual value of -$310.4 million for FY2024, which is 6648.86% down from last year.
  • Latest data reveals that P3 Health Partners reported Net Income towards Common Stockholders of -$310.4 million as of FY2024, which was down 6648.86% from -$186.4 million recorded in FY2023.
  • In the past 5 years, P3 Health Partners' Net Income towards Common Stockholders registered a high of -$31.4 million during FY2020, and its lowest value of -$310.4 million during FY2024.
  • In the last 5 years, P3 Health Partners' Net Income towards Common Stockholders had a median value of -$186.4 million in 2023 and averaged -$188.9 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first soared by 3098.58% in 2023, then crashed by 6648.86% in 2024.
  • Over the past 5 years, P3 Health Partners' Net Income towards Common Stockholders (Annual) stood at -$31.4 million in 2020, then crashed by 366.07% to -$146.4 million in 2021, then crashed by 84.51% to -$270.1 million in 2022, then surged by 30.99% to -$186.4 million in 2023, then crashed by 66.49% to -$310.4 million in 2024.
  • Its Net Income towards Common Stockholders stands at -$310.4 million for FY2024, versus -$186.4 million for FY2023 and -$270.1 million for FY2022.